Immediate Impact
1 by Nobel laureates 1 from Science/Nature 50 standout
Citing Papers
Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies
2025 Standout
Cancer therapy with antibodies
2024 Standout
Works of Matko Kalac being referenced
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma
2017
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Matko Kalac | 213 | 140 | 85 | 155 | 35 | 402 | |
| Gaosheng Huang | 147 | 118 | 66 | 86 | 34 | 419 | |
| Monica Civallero | 174 | 171 | 74 | 176 | 40 | 398 | |
| Maria Antonella Laginestra | 146 | 139 | 78 | 145 | 25 | 370 | |
| Jennifer Kimberly Lue | 237 | 140 | 90 | 164 | 36 | 417 | |
| Shinsuke Mizutani | 182 | 109 | 56 | 123 | 50 | 385 | |
| Jonathan A. Schumacher | 133 | 61 | 61 | 119 | 25 | 362 | |
| Danielle Shafer | 168 | 148 | 46 | 81 | 30 | 388 | |
| Hong Liu | 95 | 87 | 84 | 94 | 33 | 414 | |
| Lianqun Qiu | 217 | 76 | 145 | 84 | 32 | 455 | |
| Lin Pan | 191 | 116 | 36 | 89 | 28 | 422 |
All Works
Loading papers...